Vanta Bioscience Limited (BOM:540729)

Market Cap	95.63M -73.2%
Revenue (ttm)	12.35M -73.0%
Net Income	-45.25M
EPS	-6.74
Shares Out	6.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,750
Average Volume	5,325
Open	15.00
Previous Close	14.90
Day's Range	15.00 - 15.15
52-Week Range	14.71 - 31.33
Beta	0.82
RSI	39.41
Earnings Date	Jul 29, 2026

About Vanta Bioscience

Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. The company offers a range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. It also provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, an...

• Industry: Commercial Physical and Biological Research
• Founded: 2016
• Employees: 36
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540729

Financial Performance

In fiscal year 2025, Vanta Bioscience's revenue was 19.64 million, a decrease of -79.80% compared to the previous year's 97.23 million. Losses were -47.75 million, 106.2% more than in 2024.